An expert consensus report on the clinical use of the Vycross(®) hyaluronic acid VYC‐25 L filler

BACKGROUND: The portfolio of hyaluronic acid (HA) fillers and the techniques of administration have evolved in recent years. The latest innovation in the Vycross(®) range was the introduction of VYC‐25L (Juvéderm Volux(®); Allergan plc), a first‐in‐class filler effective for chin and facial lower th...

Descripción completa

Detalles Bibliográficos
Autores principales: Segurado, María A., Urdiales‐Gálvez, Fernando, Benítez, Paula A., Carrasco, Sara, Díaz, Iratxe, Escoda, Nuria, Farollch‐Prats, Lisandro, Figueiredo, Vitor, Ortíz, Francisco, Sebastián, María Consuelo, Uva, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Fillers/Fat
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292743/
https://www.ncbi.nlm.nih.gov/pubmed/34460984
http://dx.doi.org/10.1111/jocd.14398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292743/
https://www.ncbi.nlm.nih.gov/pubmed/34460984
http://dx.doi.org/10.1111/jocd.14398

Ejemplares similares